SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-23-201207
Filing Date
2023-08-02
Accepted
2023-08-02 08:59:22
Documents
6
Effectiveness Date
2023-08-02

Document Format Files

Seq Description Document Type Size
1 S-8 d712199ds8.htm S-8 40931
2 EX-5.1 d712199dex51.htm EX-5.1 8962
3 EX-23.2 d712199dex232.htm EX-23.2 2175
4 EX-FILING FEES d712199dexfilingfees.htm EX-FILING FEES 15282
5 GRAPHIC g712199g0727234713915.jpg GRAPHIC 1649
6 GRAPHIC g712199g0727235540806.jpg GRAPHIC 5840
  Complete submission text file 0001193125-23-201207.txt   79001
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-273593 | Film No.: 231133882
SIC: 2834 Pharmaceutical Preparations